血清乳酸脱氢酶可预测口咽癌放疗患者生存
本研究回顾性分析2008至2018年接受根治性放疗的101例口咽癌患者,评估HPV阳性与阴性者的预后因素。中位随访68个月,5年总生存率69.8%。多因素分析显示吸烟≥30包年和血清LDH≥202是不良生存的独立相关因素。
要点
- 高LDH(≥202)与口咽癌根治性放疗后不良生存独立相关。
- 吸烟≥30包年也是独立不良预后因素。
- LDH预测作用在HPV阳性与阴性患者中均存在。
核心结论
- 高LDH水平预测口咽癌患者根治性放疗后不良生存,且适用于HPV阳性和阴性患者。
研究设计与样本
- 回顾性研究,纳入2008至2018年接受根治性放疗的101例口咽癌患者。
主要发现
- 存活患者中位随访68个月(范围8-164个月),5年总生存率为69.8%。
- 单因素分析中,男性、吸烟≥30包年、ECOG体能状态≥1、TNM分期III-IV期(第8版)、HPV阴性、LDH≥202、C反应蛋白/白蛋白比值≥0.15、淋巴细胞/单核细胞比值<2.90与较差生存相关。
- 多因素分析中,吸烟≥30包年(p < 0.01)和LDH≥202(p = 0.02)与不良生存独立相关。
关键数值与推荐
- LDH≥202为不良生存的独立预测阈值。
- 吸烟≥30包年为独立不良预后因素。
临床怎么用
- 对接受根治性放疗的口咽癌患者,可检测血清LDH水平以协助预后分层。
- 需关注吸烟≥30包年患者的预后风险。
局限性
- 回顾性研究,样本量有限(101例),结论需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The present study aimed to evaluate the prognostic factors in human papillomavirus (HPV)-positive and HPV-negative oropharyngeal cancer (OPC) treated with definitive radiotherapy. METHODS: We retrospectively evaluated 101 patients with OPC who underwent definitive radiotherapy between 2008 and 2018. RESULTS: The median follow-up period of the surviving patients was 68 months (range, 8-164 months). The 5-year overall survival rate was 69.8%. Univariate analyses revealed that poor survival was associated with male sex, smoking ≥30 pack-years, Eastern Cooperative Oncology Group performance status ≥1, tumor-node-metastasis (TNM) stage III-IV (8th edition), HPV-negativity, serum lactate dehydrogenase (LDH) ≥202, C-reactive protein/albumin ratio ≥0.15, and lymphocyte-to-monocyte ratio <2.90. In multivariate analyses, poor survival was independently correlated with smoking ≥30 pack-years (p < 0.01) and LDH ≥202 (p = 0.02). CONCLUSIONS: The present study suggested that high LDH levels predicted poor survival after definitive radiotherapy for patients with both HPV-positive and HPV-negative OPC.
引用
- Uehara T, Doi H, Ishikawa K, et al. Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors. Head Neck. 2021. PMID: 34268826. doi:10.1002/hed.26814
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。